Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Suboxone 101: The Skinny on This Opioid-Dependence Drug

By Michele Kaufman, PHARMD, BCGP | on October 23, 2018 | 1 Comment
Pharm 360
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Suboxone 101: The Skinny on This Opioid-Dependence Drug

Additionally, it is extremely dangerous to self-administer non-prescribed benzodiazepines or other CNS depressants (including alcohol) while taking BTODs.

You Might Also Like
  • Indivior, Drug to Fight Opioid Addiction, Approved by U.S. FDA
  • ED-Initiated Buprenorphine Cost-Effective for Opioid Dependence
  • A Quick Guide to Buprenorphine Products
Explore This Issue
ACEP Now: Vol 37 – No 10 – October 2018

Buprenorphine/Naloxone Products List4

Buprenorphine/naloxone products include:

  • Suboxone SL film in strengths of buprenorphine 2 mg/naloxone 0.5 mg, buprenorphine 4 mg/naloxone 1 mg, buprenorphine 8 mg/naloxone 2 mg, and buprenorphine 12 mg/naloxone 3 mg
  • Bunavail buccal film in strengths of buprenorphine 2.1 mg/naloxone 0.3 mg, buprenorphine 4.2 mg/naloxone 0.7 mg, and buprenorphine 6.3 mg/naloxone 1 mg
  • Zubsolv SL tablet in strengths of buprenorphine 0.7 mg/naloxone 0.18 mg, buprenorphine 1.4 mg/naloxone 0.36 mg, buprenorphine 2.9 mg/naloxone 0.71 mg, buprenorphine 5.7 mg/naloxone 1.4 mg, buprenorphine 8.6 mg/naloxone 2.1 mg, and buprenorphine 11.4 mg/naloxone 2.9 mg
  • Buprenorphine/naloxone generic SL tablet, in strengths of buprenorphine 2 mg/naloxone 0.5 mg, buprenorphine 8 mg/naloxone 2 mg, buprenorphine 12 mg/naloxone 3 mg, and buprenorphine 16 mg/naloxone 4 mg

Price4

Sixty pouches of Suboxone SL film cost approximately $328 (2 mg/0.5 mg), $587 (4 mg/1 mg and 8 mg/2 mg), and $1,174 (12 mg/3 mg), according to Lexi-Drugs. Thirty generic SL tablets of buprenorphine/naloxone cost approximately $175 (2 mg/0.5 mg) and $313 (8 mg/2 mg).


Read the emergency medicine commentary on Suboxone.


Dr. Kaufman is a board-certified geriatric pharmacist, a pharmacist at NewYork-Presbyterian/Lower Manhattan Hospital, and a freelance medical writer and editor.

References

  1. Drugs @ FDA, Suboxone prescribing information. U.S. Food and Drug Administration website. Accessed September 28, 2018.
  2. Controlled Substances Act, 21 USC §823(g) (1974).
  3. Buprenorphine. Substance Abuse and Mental Health Services Administration website. Accessed September 28, 2018.
  4. Buprenorphine/naloxone products. Lexicomp Online [database online]. Hudson, OH: Wolters Kluwer Clinical Drug Information. Updated May 3, 2018. Accessed May 15, 2018.
  5. Office-based buprenorphine therapy for opioid dependence: important information for prescribers. BTOD REMS website. Accessed September 28, 2018.

Pages: 1 2 | Single Page

Topics: BuprenorphineDrug AbuseNaloxoneOpioid CrisisSuboxone

Related

  • Prehospital Buprenorphine Is a Powerful Tool in the Opioid-Crisis Fight

    June 4, 2025 - 0 Comment
  • How to Manage Elderly Patient Pain without Opioids

    February 13, 2024 - 0 Comment
  • Are Opiates Futile in Low Back Pain?

    October 15, 2023 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

One Response to “Suboxone 101: The Skinny on This Opioid-Dependence Drug”

  1. November 25, 2019

    Brad Erwin Reply

    Thanks for mentioning that Suboxone should be administered as a part of a program that includes support and counseling because it is a schedule III substance used to combat opioid dependence. My brother is trying to get rid of his addiction so that he can start to take back his life and focus on the parts of life that are important to him. I will be sure to recommend he look for a treatment center that has the necessary qualifications to administer suboxone so that he can start on the right foot for this goal.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603